Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Update on HemispheRx Biopharma's Ampligen

May 12, 1997

MS&D reports potent and selective 5-HT1Dalpha agonists

May 9, 1997

Improved analgesic/antiinflammatory urea derivatives disclosed by Novartis

May 9, 1997

Medtronic and Cephalon to copromote Intrathecal Baclofen Therapy

May 9, 1997

Lilly and Scios AD collaboration

May 9, 1997

Taisho to develop Tanabe MAO-A inhibitor

May 8, 1997

Novo Nordisk describes heterocyclic compounds for neurogenic pain/inflammation

May 8, 1997

ECE inhibitors from Santen

May 8, 1997

FDA clears generic antidepressant from Teva

May 7, 1997

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...